NCT06580938
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06580938
Title A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Highlands Oncology Group Rogers Arkansas 72758 United States Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
Presbyterian/St. Lukes Medical Center Denver Colorado 80218 United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Drug Development Unit Sarasota Florida 34232 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field